Literature DB >> 24395449

Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?

Carolyn J Bevan1, Bruce A C Cree1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24395449     DOI： 10.1001/jamaneurol.2013.5486

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  56 in total

Review 1.  Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Authors:  Jens Ingwersen; Orhan Aktas; Hans-Peter Hartung
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 2.  Treatment decisions in multiple sclerosis - insights from real-world observational studies.

Authors:  Maria Trojano; Mar Tintore; Xavier Montalban; Jan Hillert; Tomas Kalincik; Pietro Iaffaldano; Tim Spelman; Maria Pia Sormani; Helmut Butzkueven
Journal:  Nat Rev Neurol       Date:  2017-01-13       Impact factor: 42.937

3.  Headache in the course of multiple sclerosis: a prospective study.

Authors:  Marcel Gebhardt; Peter Kropp; Frank Hoffmann; Uwe K Zettl
Journal:  J Neural Transm (Vienna)       Date:  2018-11-30       Impact factor: 3.575

4.  Improved Detection of New MS Lesions during Follow-Up Using an Automated MR Coregistration-Fusion Method.

Authors:  A Galletto Pregliasco; A Collin; A Guéguen; M A Metten; J Aboab; R Deschamps; O Gout; L Duron; J C Sadik; J Savatovsky; A Lecler
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

5.  [Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research].

Authors:  J-P Stellmann; K H Stürner; F Ufer; S Havemeister; J Pöttgen; F Ayuk Ayuketang; N Kröger; M A Friese; C Heesen
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

6.  Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model.

Authors:  Martin Stangel; Iris Katharina Penner; Boris A Kallmann; Carsten Lukas; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2015-01       Impact factor: 6.570

7.  Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.

Authors:  A Lecler; I El Sanharawi; J El Methni; O Gout; P Koskas; J Savatovsky
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

8.  Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  J Burman; K Kirgizov; K Carlson; M Badoglio; G L Mancardi; G De Luca; B Casanova; J Ouyang; R Bembeeva; J Haas; P Bader; J Snowden; D Farge
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

Review 9.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 10.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.